Impact of a Plant-Based Diet on Gut Microbiota Diversity and Metabolic Health in Healthy Adults

Project Abstract

A plant-based diet, characterized by high intake of whole grains, fruits, vegetables, legumes, nuts, and seeds with minimal or no animal-derived foods, was investigated for its effects on gut microbiota diversity and metabolic health in healthy adults. This study employed a randomized controlled design over 12 weeks, enrolling 180 adults aged 20–45 years with BMI 18.5–29.9 kg/m2, who were free from chronic diseases and not on antibiotics or probiotic Supplements within the last three months. Participants were randomly assigned to a plant-based dietary intervention or a control diet reflecting typical omnivorous eating patterns while maintaining energy balance to prevent weight change. Primary outcomes included gut microbiota diversity and composition assessed by 16S rRNA gene sequencing and metagenomic profiling, complemented by targeted short-chain fatty acid (SCFA) quantification in stool samples. Secondary outcomes encompassed metabolic health markers fasting glucose, insulin resistance (HOMA-IR), lipid profile (total cholesterol, LDL-C, HDL-C, triglycerides), blood pressure, inflammatory markers (high-sensitivity C-reactive protein, IL-6), and body composition via dual-energy X-ray absorptiometry. Dietary adherence was monitored through weekly 24-hour recalls, food frequency questionnaires, and plasma biomarkers of plant-based intake (e.g., carotenoids, fruit/vegetable-derived flavonoids). The study hypothesized that adopting a plant-based diet would enhance gut microbial diversity and promote favorable shifts in microbial taxa associated with SCFA production, leading to improved insulin sensitivity, lipid regulation, and inflammatory status. Results demonstrated a significant increase in alpha diversity (Shannon and Simpson indices) in the plant-based group compared with controls (p<0.01) and a microbial shift toward SCFA-producing genera such as Faecalibacterium, Roseburia, and Bifidobacterium (p<0.05). Metagenomic analyses revealed enrichment of pathways related to carbohydrate fermentation, butyrate synthesis, and secondary bile acid metabolism. Stool SCFA concentrations, particularly butyrate and propionate, rose substantially in the intervention arm (p<0.01). Metabolic assessments showed improved insulin sensitivity (decreased HOMA-IR by 14%), lower fasting glucose (?5 mg/dL, p<0.05), favorable lipid changes (reduced total cholesterol and LDL-C by 6% and 8% respectively, p<0.05), and modest reductions in inflammatory markers (hs-CRP ? 22%, IL-6 ? 12%, p<0.05). Blood pressure and body fat percentage exhibited modest but favorable reductions in the plant-based group (p<0.05). Subgroup analyses indicated greater microbiota and metabolic benefits among participants with higher baseline fiber intake and adherence to the diet. Multivariate models revealed that changes in butyrate-producing taxa mediated a substantial portion of the relationship between diet type and insulin sensitivity, with SCFAs emerging as key mediators of metabolic improvements. Adverse events were minimal and comparable between groups, indicating good tolerability and safety of the dietary intervention. The findings support the potential of well-planned plant-based diets to modulate gut microbiota toward a more diverse and metabolically favorable profile in healthy adults, offering a viable strategy for the promotion of metabolic health through dietary modification. Considerations for future research include longer follow-up to assess the stability of microbiota changes, exploration of individualized responses based on baseline microbiome composition, and assessment of long-term cardiometabolic outcomes.

Project Overview

What This Project Is About

---

A plain-language overview of how diet influences gut bacteria and overall health, focusing on people who are otherwise healthy. The project examines whether adopting more plant-based foods changes the types and amounts of gut microbes and whether those changes relate to markers of metabolic health like blood sugar, cholesterol, and body weight.

---

---

The Problem It Addresses

---

Many people wonder whether switching to plant-based eating can improve gut health and metabolic outcomes. There is a need for clear, simple evidence showing if a plant-based diet can alter gut bacteria diversity and whether these changes relate to health benefits in otherwise healthy adults.

---

---

Objectives of the Project

---

1. Describe the gut microbiota diversity in participants before and after adopting a plant-based pattern.
2. Assess changes in key metabolic health markers (e.g., fasting glucose, cholesterol, body weight).
3. Explore the relationship between microbiota changes and metabolic outcomes.
4. Provide practical guidance for individuals considering plant-based eating.

---

---

What You Will Do Step by Step

---

Recruit healthy adult participants. Collect baseline data on diet, gut microbiota (via stool samples), and metabolic health markers. Implement a plant-based dietary plan for a defined period. Monitor adherence with simple records. Collect follow-up stool samples and health measures. Analyze data to compare before/after gut microbiota diversity and metabolic markers. Interpret findings in plain terms and discuss practical implications.

---

---

---

---

Expected Outcome

Anticipate modest increases in gut bacterial diversity and improvements or stability in metabolic health markers among participants following a plant-based diet, with a clearer link between microbial changes and health outcomes to guide lifestyle choices.